OBJECTIVES: Identify the underlying role of resting heart rate variability (HRV) in the hearts response to graded exercise testing (GXT). METHODS: Resting 5-min HRV and heart rate (HR) measurements were made in 33 volunteers (19 males, median age 34, range 25-63 years and 14 females median age 48, range 21-63 years). Measures of VO2 peak and HR obtained during a maximal GXT and heart rate recovery (HRR) post-GXT were assessed for associations with resting HRV. Differences and effect size (d) for measures of HRV were assessed between groups based on established risk cut-points for resting, exercise and recovery HR responses. RESULTS: Small associations were observed for the majority of resting HRV and GXT HR responses (best r value = -0.27, P > 0.05). Measures of HRV demonstrated moderate associations with HRR (best r value = 0.46, P < 0.05) and were able to predict a negative risk HRR. In contrast to other dependent variables, measures of HRV were consistently able to demonstrate significant and moderate to large (d = 0.9-2.0) differences between groups based on literature defined prognostic HR cut-points. INTERPRETATION: Small associations with HR responses to exercise prevent their accurate prediction from resting HRV. Data support the use of vagally mediated resting HRV in predicting better HRR. Lower resting autonomic modulations underlined high risk resting and exercise HR responses. Resting short-term HRV measurements should be considered when assessing cardiac autonomic health from the HR response before, during and/or after exercise.
OBJECTIVES: Identify the underlying role of resting heart rate variability (HRV) in the hearts response to graded exercise testing (GXT). METHODS: Resting 5-min HRV and heart rate (HR) measurements were made in 33 volunteers (19 males, median age 34, range 25-63 years and 14 females median age 48, range 21-63 years). Measures of VO2 peak and HR obtained during a maximal GXT and heart rate recovery (HRR) post-GXT were assessed for associations with resting HRV. Differences and effect size (d) for measures of HRV were assessed between groups based on established risk cut-points for resting, exercise and recovery HR responses. RESULTS: Small associations were observed for the majority of resting HRV and GXT HR responses (best r value = -0.27, P > 0.05). Measures of HRV demonstrated moderate associations with HRR (best r value = 0.46, P < 0.05) and were able to predict a negative risk HRR. In contrast to other dependent variables, measures of HRV were consistently able to demonstrate significant and moderate to large (d = 0.9-2.0) differences between groups based on literature defined prognostic HR cut-points. INTERPRETATION: Small associations with HR responses to exercise prevent their accurate prediction from resting HRV. Data support the use of vagally mediated resting HRV in predicting better HRR. Lower resting autonomic modulations underlined high risk resting and exercise HR responses. Resting short-term HRV measurements should be considered when assessing cardiac autonomic health from the HR response before, during and/or after exercise.
Authors: Nicholas J Leeper; Frederick E Dewey; Euan A Ashley; Marcus Sandri; Swee Yaw Tan; David Hadley; Jonathan Myers; Victor Froelicher Journal: Circulation Date: 2007-01-22 Impact factor: 29.690
Authors: Xavier Jouven; Jean-Philippe Empana; Peter J Schwartz; Michel Desnos; Dominique Courbon; Pierre Ducimetière Journal: N Engl J Med Date: 2005-05-12 Impact factor: 91.245
Authors: D Van Hoogenhuyze; N Weinstein; G J Martin; J S Weiss; J W Schaad; X N Sahyouni; D Fintel; W J Remme; D H Singer Journal: Am J Cardiol Date: 1991-12-15 Impact factor: 2.778
Authors: Aljoša Danieli; Lara Lusa; Nejka Potočnik; Bernard Meglič; Anton Grad; Fajko F Bajrović Journal: Clin Auton Res Date: 2014-02-08 Impact factor: 4.435
Authors: Guilherme Eckhardt Molina; Keila Elizabeth Fontana; Luiz Guilherme Grossi Porto; Luiz Fernando Junqueira Journal: Clin Auton Res Date: 2016-08-10 Impact factor: 4.435
Authors: M Berkelaar; E M W Eekhoff; A M C Simonis-Bik; D I Boomsma; M Diamant; R G Ijzerman; J M Dekker; L M 't Hart; E J C de Geus Journal: Diabetologia Date: 2013-02-13 Impact factor: 10.122
Authors: Hugo Njemanze; Charlotte Warren; Christopher Eggett; Guy A MacGowan; Matthew G D Bates; Mario Siervo; Srdjan Ivkovic; Michael I Trenell; Djordje G Jakovljevic Journal: Oncotarget Date: 2016-11-22